Skip to main content
SpringerLink
Log in

Lithium does not interact, with haloperidol in the dopaminergic pathways of the rat brain

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Prophylactic treatment with lithium has been reported to prevent haloperidol-induced dopamine (DA) receptor supersensitivity. If such an effect exists, then lithium may be useful in the prevention of tardive dyskinesia, which is related to the neuroleptic-induced DA hyperfunction. In the experiments reported here chronic lithium administration had no effect on DA synthesis or utilization in the nigrostriatal, mesolimbic, or mesocortical DA pathways in the rat brain. Similarly, lithium had no effect on the increase in DA metabolism induced by the acute administration of haloperidol. Also, chronic lithium treatment failed to modify the biochemical tolerance which developed after prolonged administration of the neuroleptic drug. Supersensitivity of the presynaptic DA receptors, which was induced by prolonged exposure to haloperidol, likewise was unaffected by prophylactic lithium treatment. We conclude that lithium does not affect changes in DA metabolism or receptor supersensitivity induced by haloperidol. These results do not support the use of lithium in neurological disorders that may be related to neuroleptic-induced DA receptor supersensitivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Allikmets LH, Stanley M, Gershon S (1979) The effect of lithium on chronic haloperidol enhanced apomorphine aggression in rats. Life Sci 25:165–170

    Google Scholar 

  • Cacopoulos NC, Spokes EG, Bird ED, Roth RH (1979) Antipsychotic drug action in schizophrenic patients: Effects on cortical dopamine metabolism after long-term treatment. Science 205:1405–1407

    Google Scholar 

  • Baldessarini RJ (1977) Schizophrenia. N Engl J Med 297:988–995

    Google Scholar 

  • Bannon MJ, Michaud R, Roth RH (1981) Mesocortical dopamine neurons lack of autoreceptors modulating dopamine synthesis. Molec Pharmacol 19:270–275

    Google Scholar 

  • Bliss EL, Ailion J (1970) The effect of lithium on brain monoamines. Brain Res 24:305–310

    Google Scholar 

  • Bowers MB, Rozitis A (1976) Brain homovanillic acid. Regional changes over time with antipsychotic drugs. Eur J Pharmacol 39:109–115

    Google Scholar 

  • Burke RE, Fahn S, Jankovic J, Marsden CD Collomp S, Ilson J (1982) Tardive dystonia: Late and persistent dystonia induced by antipsychotic drugs. Neurology 32:1335–1346

    Google Scholar 

  • Burt DR, Creese I, Snyder SH (1977) Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain. Science 196:326–328

    Google Scholar 

  • Carlsson A (1977) Does dopamine play a role in schizophrenia? Psychol Med 7:583–597

    Google Scholar 

  • Coffey CE, Ross DR, Ferren EL, Sullivan JL, Olanow CW (1982) Treatment of the “on-off” phenomenon in parkinsonism with lithium carbonate. Ann Neurol 12:375–379

    Google Scholar 

  • Costentin J, Protais P (1978) Increased in vivo binding of 3H-pimozid in mouse striatum following repeated administration of haloperidol. Life Sci 23:1758–1790

    Google Scholar 

  • Dalen P (1973) Lithium therapy in Huntington's chorea and tardive dyskinesia. Lancet 1:107

    Google Scholar 

  • Eroglu L, Hizal A, Koyuncugl U (1981) The effect of long term concurrent administration of chlorpromazine and lithium on the striatal and frontal corticol dopamine metabolism in rats. Psychopharmacology 73:84–86

    Google Scholar 

  • Gallager DW, Pert A, Bunney WE (1978) Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium. Nature 273:309–312

    Google Scholar 

  • Gianutsos F, Hynes MD, Lal H (1975) Enhancement of apomorphine-induced inhibition of striatal dopamine turnover following chronic haloperidol. Biochem Pharmacol 24:581–582

    Google Scholar 

  • Ho AKS, Loh HH, Graves F, Hitzmann RJ, Gershon S, (1970) The effect of prolonged lithium treatment on the synthesis rate and turnover of monoamines in brain regions of the rat. Eur J Pharmacol 10:72–78

    Google Scholar 

  • Hyttel J (1975) Long-term effects of teflutixol on the synthesis and endogenous levels of mouse brain catecholamines J Neurochem 25:681–686

    Google Scholar 

  • Iwatsubo K, Clovet CH (1975) Dopamine-sensitive adenylate cyclase of the caudate nucleus of rats treated with morphine or haloperidol. Biochem Pharmacol 24:1499–1503

    Google Scholar 

  • Johnson G, Gershon S, Hekimian LJ (1968) Controlled evaluation of lithium and chlorpromazine in the treatment of manic states: An interim, report. Comp Psychiatry 9:563–573

    Google Scholar 

  • Juhl RP, Tsuang MT, Perry PT (1977) Concomitant administration of haloperidol and lithium carbonate in acute mania. Dis Nerv Syst 38:675–676

    Google Scholar 

  • Karoum F, Neff NH, Wyatt RJ (1977) The dynamics of dopamine metabolism in various regions of rat brain. Eur J Pharmacol 44:311–318

    Google Scholar 

  • Klawans HL (1973) The pharmacology of tardive dyskinesia. Am J Psychiatry 130:82–86

    Google Scholar 

  • Klawans HL, Rubovits R (1972) An experimental model of tardive dyskinesia. J Neural Transm 33:235–246

    Google Scholar 

  • Krishna NR, Taylor MA, Abrams SR (1978) Combined haloperidol and lithium carbonate in treating manic patients. Comp Psychiatry 19:119–120

    Google Scholar 

  • Lieberman A, Gophinathan G (1982) Treatment of “on-off” phenomenon with lithium. Ann Neurol 12:402

    Google Scholar 

  • Mackay AVP, Sheppard GP, Saha BK, Motley B, Johnson AL, Marsden CD (1980) Failure of lithium treatment in established tardive dyskinesia. Psychol Med 10:583–587

    Google Scholar 

  • Meller E, Friedman E (1981) Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced DOPAC increase in rat striatum. Eur J Pharmacol 76:25–29

    Google Scholar 

  • Muller P, Seeman P (1977) Brain neurotransmitter receptors after long-term haloperidol, dopamine, acetylcholine, serotonin, alpha-noradrenergic and noloxone receptors. Life Sci 21:1751–1758

    Google Scholar 

  • Nowyeky M, Roth R (1977) Presynaptic dopamine receptors. Development of supersensitivity following treatment with flufenazine decanoate. Naunyn-Schmiedeberg's Arch Pharmacol 300:247–254

    Google Scholar 

  • Ohman R, Larrson M, Nilsson IM, Engel J, Carlsson A (1977) Neurometabolic and behavioral effects of haloperidol in relation to drug levels in the serum and brain. Naunyn-Schmiedeberg's Arch Pharmacol 299:105–114

    Google Scholar 

  • Pert A, Rosenblatt JE, Sivitt C, Pert CB, Bunney WE (1978) Longterm treatment with lithium prevents the development of dopamine receptor supersensitivity. Science 201:171–173

    Google Scholar 

  • Prien RF, Caffey EM, Klett CJ (1972) A comparison of lithium carbonate and chlorpromazine in the treatment of excited schizoaffectives. Arch Gen Psychiatry 27:182–189

    Google Scholar 

  • Reches A, Wagner HR, Jackson V, Fahn S (1982a) The effect of chronic l-dopa administration of supersensitive pre- and postsynaptic dopaminergic receptors in rat brain. Life Sci 31:37–44

    Google Scholar 

  • Reches A, Jiang D, Fahn S (1982b) Catechol-o-methyltransferase inhibition by U-0521 increases striatal utilization of levodopa. Naunyn-Schmiedeberg's Arch Pharmacol 320:34–37

    Google Scholar 

  • Reches A, Wagner HR, Jackson V, Fahn S (1982c) Chronic lithium administration has no effect on haloperidol-induced supersensitivity of pre- and postsynaptic dopamine receptors in rat brain. Brain Res 246:172–177

    Google Scholar 

  • Reda FA, Scanlan JM, Kemp K, Escobar JI (1974) Treatment of tardive dyskinesia with lithium carbonate. N Engl J Med 291:850

    Google Scholar 

  • Scatton B (1977) Differential regional development of tolerance to increases in dopamine turnover upon repeated neuroleptic administration. Eur J Pharmacol 46:363–369

    Google Scholar 

  • Simpson GM, Branchley MH, Lee JH, Votashevsky A, Zoubok B (1976) Lithium in tardive dyskinesia. Pharmakopsychologie 9:76–80

    Google Scholar 

  • Smith RC, Davis JM (1976) Behavioral evidence for supersensitivity after chronic administration of halidol, clozapine and thioridazine. Life Sci 19:725–732

    Google Scholar 

  • Staunton DA, Magistretti PJ, Shoemaker WJ, Bloom FE (1982a) Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. I. Locomotor activity and behavioral supersensitivity. Brain Res 232:391–400

    Google Scholar 

  • Staunton DA, Magistretti PH, Shoemaker WJ, Deyo SN, Bloom FE (1982b) Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity. Brain Res 232:401–412

    Google Scholar 

  • Tarsy D, Baldessarini RJ (1974) Behavioral supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamine. Neuropharmacology 13:927–940

    Google Scholar 

  • Ungerstedt U (1971) Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand [Suppl] 367:1–122

    Google Scholar 

  • Verimer T, Goodale DB, Long JP, Flynn JR (1980) Lithium effects on haloperidol-induced pre- and postsynaptic dopamine receptor supersensitivity. J Pharm Pharmacol 32:665

    Google Scholar 

  • Waldmier PC, Maitre L (1976) On the relevance of preferential increases of mesolimbic versus striatal dopamine turnover for the prediction of antipsychotic activity of psychotropic drugs. J Neurochem 27:589–597

    Google Scholar 

  • Walters JR, Roth RH (1976) Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors. Naunyn-Schmiedeberg's Arch Pharmacol 296:5–14

    Google Scholar 

  • Wheeler SC, Roth RH (1980) Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment. Naunyn-Schmiedeberg's Arch Pharmacol 312:151–159

    Google Scholar 

  • Wilk S, Watson E, Travis B (1975) Evaluation of dopamine metabolism in rat striatum by a gas chromatographic technique. Eur J Pharmacol 30:238–243

    Google Scholar 

  • Wooten GF, Rubin EH (1982) Neuroleptic but not denervation-induced dopamine supersensitivity is blocked by lithium. Neurology 32:A65

    Google Scholar 

  • Yarbrough C (1975) Supersensitivity of caudate neurons after repeated administration of haloperidol. Eur J Pharmacol 31:367–369

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Hadassah Medical Center and The Hebrew University, Jerusalem, Israel

    Avinoam Reches

  2. Neurological Institute, Columbia University, College of Physicians and Surgeons, 10032, New York, NY, USA

    Vernice Jackson-Lewis & Stanley Fahn

Authors
  1. Avinoam Reches
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vernice Jackson-Lewis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stanley Fahn
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reches, A., Jackson-Lewis, V. & Fahn, S. Lithium does not interact, with haloperidol in the dopaminergic pathways of the rat brain. Psychopharmacology 82, 330–334 (1984). https://doi.org/10.1007/BF00427680

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00427680

Key words

Search

Navigation